Targeting podocyte-associated diseases☆
Jan Willem Leeuwis(University Medical Center Utrecht), Roel Goldschmeding(University Medical Center Utrecht), Robbert J. Kok(Utrecht University), Amélie Dendooven(University of Antwerp), Tri Q. Nguyen(Utrecht University)
Cited by 113
Related Papers
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
Diverse origins of the myofibroblast—implications for kidney fibrosis
|Nature Reviews Nephrology|2015|305
Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges
|International Journal of Pharmaceutics|2016|285